As a model to demonstrate this concept, we investigated the epigenomic dependencies of Tet methycytosine dioxygenase 2, Tet2. Inactivating mutations to TET2 are amongst the most prevalent in CH and are associated with the highest relative risk of disease development14. Here, TET2 is linked to cyclic hematopoiesis.